By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Scancell, Ltd. 

P.O. Box 6457

Nottingham    NG5 1QA  United Kingdom
Phone: 44-0-115-962-8033 Fax: +44-0-115-962-8033


Key Statistics

Ownership: Public

Web Site: Scancell
Symbol: SCNLF


Company News
Scancell (SCNLF) Delays Melanoma Trial 9 to 12 Months to Whip Up New Batch of Cancer Vaccine 7/7/2016 6:45:44 AM
Scancell (SCNLF) Suspends Dosing in Melanoma Trial Due to Quality Issues 6/17/2016 6:34:42 AM
SyndicateRoom Brings Crowd To £6.1 Million Fundraise For Cancer Treatment Company 4/1/2016 9:10:11 AM
Scancell Release: Interim Results For The Six Months Ended 31 October 2015 1/27/2016 9:01:46 AM
Scancell Release: Early Immune Effect Of SCIB1 Cancer Vaccine Observed In Blood By ImmunTraCkeR Companion Diagnostic 1/11/2016 9:51:55 AM
Scancell Release: Directorate Change 1/7/2016 10:57:59 AM
Scancell Release: Key Moditope Paper Published In Cancer Research 1/5/2016 10:15:22 AM
Scancell To Conduct Phase II Checkpoint Inhibitor Combination Study With SCIB1 With Leading Us Melanoma Specialists 12/18/2015 9:31:56 AM
Scancell: Translating Innovative Science Into Ground-Breaking New Products 10/20/2015 12:32:15 PM
Scancell Strengthens Operational And Clinical Development Expertise 10/14/2015 10:14:28 AM